Methylphenidate Hydrochlorid · #31 of 35 active shortages by FDA posting duration
Brand: RELEXXII
FDA lists Methylphenidate Hydrochlorid as Active Shortage (Vertical Pharmaceuticals, LLC).
Availability on file: Unavailable
Methylphenidate Hydrochloride Tablet, Extended Release: Active Shortage
Unavailable 43 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Methylphenidate Hydrochloride Tablet, Extended Release
- Manufacturer
- Vertical Pharmaceuticals, LLC
- Dosage Form
- Tablet
- Presentation
- Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)
- Package NDC
- 68025-097-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jul 26, 2023
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Psychiatry
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: TBD
Full Drug Profile
methylphenidate
Side effects, interactions, warnings & more
Nearby, Other Methylphenidate Shortage Records
Methylphenidate Film, Extended Release
Noven Pharmaceuticals, Inc.
Film, Extended Release
Methylphenidate Film, Extended Release
Noven Pharmaceuticals, Inc.
Film, Extended Release
Methylphenidate Film, Extended Release
Noven Pharmaceuticals, Inc.
Film, Extended Release
Methylphenidate Film, Extended Release
Noven Pharmaceuticals, Inc.
Film, Extended Release
Methylphenidate Hydrochloride Tablet, Extended Release
Vertical Pharmaceuticals, LLC
Tablet
Methylphenidate Hydrochloride Tablet, Extended Release
Janssen Pharmaceuticals
Tablet
FDA reason on file: Estimated recovery: TBD. General shortage guidance lives on the tracker hub.